U.S. Microbial Api Market Size & Outlook, 2023-2030
U.S. microbial api market, 2018-2030 (US$M)
Related Markets
U.S. microbial api market highlights
- The U.S. microbial api market generated a revenue of USD 16,380.9 million in 2023 and is expected to reach USD 25,770.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
- In terms of segment, mammalian was the largest revenue generating host in 2023.
- Mammalian is the most lucrative host segment registering the fastest growth during the forecast period.
Microbial api market data book summary
| Market revenue in 2023 | USD 16,380.9 million |
| Market revenue in 2030 | USD 25,770.5 million |
| Growth rate | 6.7% (CAGR from 2023 to 2030) |
| Largest segment | Mammalian |
| Fastest growing segment | Mammalian |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Mammalian, Bacterial, Fungal |
| Key market players worldwide | Merck & Co Inc, DSM, CSPC Pharmaceutical Group Ltd, Teva Pharmaceutical Industries Ltd, Lonza Group Ltd, Takeda Pharmaceutical Co Ltd, Kolon Life Science, Shandong Lukang Pharmaceutical Group |
Other key industry trends
- In terms of revenue, U.S. accounted for 27.8% of the global microbial api market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. microbial api market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 3,303.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Microbial API Market Scope
Microbial API Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. microbial api market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbial api market will help companies and investors design strategic landscapes.
Mammalian was the largest segment with a revenue share of 47.31% in 2023. Horizon Databook has segmented the U.S. microbial api market based on mammalian, bacterial, fungal covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Microbial API Host Outlook (Revenue, USD Million, 2018-2030)
- Mammalian
- Bacterial
- Fungal
- U.S. Microbial API Type Outlook (Revenue, USD Million, 2018-2030)
- Antibody
- Peptide
- Protein
- Small Molecule
- Vaccine
- U.S. Microbial API Site Outlook (Revenue, USD Million, 2018-2030)
- In-house
- Outsourced
- U.S. Microbial API End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others
- U.S. Microbial API Molecule Outlook (Revenue, USD Million, 2018-2030)
- Innovative
- Generic
Reasons to subscribe to U.S. microbial api market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. microbial api market databook
-
Our clientele includes a mix of microbial api market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. microbial api market , including forecasts for subscribers. This country databook contains high-level insights into U.S. microbial api market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. microbial api market size, by host, 2018-2030 (US$M)
U.S. Microbial API Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
